Improved diastolic function in type 2 diabetes after a six month liraglutide treatment
Open accessAbstract
AIMS: To investigate whether liraglutide improves diastolic function in type 2 diabetes. METHODS: Thirty-seven patients with type 2 diabetes who began liraglutide therapy between June 2013 and May 2014 were enrolled in this observational, prospective study. 26 patients received liraglutide therapy for at least 6months. The remaining 11 patients withdrew from liraglutide therapy during the first month, were started on other hypoglycaemic therapies and formed the control group. Anthropometric, metabolic and echocardiographic parameters including pulsed wave tissue Doppler imaging were evaluated at baseline and at 6months. RESULTS: In the liraglutide group the early diastolic mitral annulus velocity on the lateral (e-lat) and medial (e-med) sides of the mitral annulus increased from 9.2±3.4 to 11.6±4.7cm/s (p<0.001) and from 6.9±1.7 to 8.4±2.6cm/s (p<0.003), respectively. The ratio of early-to-late velocities on the lateral and medial sides of the mitral annulus increased from 0.7±0.3 to 0.9±0.4 (p<0.001) and from 0.5±0.1 to 0.6±0.1 (p<0.02), respectively. The ratio of early diastolic mitral inflow velocity to early diastolic myocardial relaxation velocity decreased from 10.7±4.3 to 8.5±2.5 (p<0.005). No improvements in diastolic function was detected in the control group. Glucose control improved similarly in both groups: HA1bc -1.5% (-17mmol/mol) vs -1.3% (-14mmol/mol), p=0.67. CONCLUSIONS: In patients with type 2 diabetes, 6months liraglutide treatment was associated with a significant improvement in diastolic function.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
GLP-1RAs improve cardiac function in patients with T2DM.
“In mechanistic studies, GLP-1RAs were shown to improve cardiac function in patients with T2DM.”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 14,019 · see citing works
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367 · see citing works
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896 · see citing works
Recommendations for the evaluation of left ventricular diastolic function by echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelisa, A. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep007 · Cited by 3,351 · see citing works
Ommen, S. R., Nishimura, R. A., Appleton, C. P., Miller, F. A., Oh, J. K., Redfield, M. M., & Tajik, A. J. (2000) · Circulation · doi:10.1161/01.cir.102.15.1788 · Cited by 2,790 · see citing works
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835 · see citing works
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc12-s064 · Cited by 1,494 · see citing works
Mor‐Avi, V., Lang, R. M., Badano, L. P., Bëlohlávek, M., Cardim, N. M., Dérumeaux, G., Galderisi, M., Marwick, T. H., Nagueh, S. F., Sengupta, P. P., et al. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.01.015 · Cited by 1,258 · see citing works
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0012 · Cited by 912 · see citing works
Nikolaidis, L. A., Mankad, S., Sokos, G. G., Miske, G., Shah, A., Elahi, D., & Shannon, R. P. (2004) · Circulation · doi:10.1161/01.cir.0000120505.91348.58 · Cited by 901 · see citing works
Sokos, G. G., Nikolaidis, L. A., Mankad, S. V., Elahi, D., & Shannon, R. P. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.08.211 · Cited by 654 · see citing works
Diastolic Dysfunction in Normotensive Men with Well-Controlled Type 2 Diabetes
Poirier, P., Bogaty, P. M., Garneau, C., Marois, L., & Dumesnil, J.-G. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.5 · Cited by 612 · see citing works
Noyan-Ashraf, M. H., Momen, M. A., Ban, K., Sadi, A.-M., Zhou, Y.-Q., Riazi, A. M., Baggio, L. L., Henkelman, R. M., Husain, M., & Drucker, D. J. (2009) · Diabetes · doi:10.2337/db08-1193 · Cited by 575 · see citing works
Yu, C., Sanderson, J. E., Marwick, T. H., & Oh, J. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.078 · Cited by 570 · see citing works
Nikolaidis, L., Elahi, D., Hentosz, T., Doverspike, A., Huerbin, R., Zourelias, L., Stolarski, C. J., Shen, Y.-T., & Shannon, R. (2004) · Circulation · doi:10.1161/01.cir.0000139339.85840.dd · Cited by 546 · see citing works
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 527 · see citing works
Garcia, M. J., Ares, M. A., Asher, C. R., Rodríguez, L., Vandervoort, P., & Thomas, J. D. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00496-2 · Cited by 474 · see citing works
From, A. M., Scott, C. G., & Chen, H. H. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.003 · Cited by 469 · see citing works
Vilsbøll, T., Zdravkovic, M., Le-Thi, T., Krarup, T., Schmitz, O., Courrèges, J. P., Verhoeven, R., Bugáňová, I., & Madsbad, S. (2007) · Diabetes Care · doi:10.2337/dc06-2593 · Cited by 467 · see citing works
Wei, Y., & Mojsov, S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01430-9 · Cited by 450 · see citing works
Gulati, V. K., Katz, W. E., Follansbee, W. P., & Gorcsan, J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00033-1 · Cited by 415 · see citing works
Left Ventricular Diastolic Dysfunction as an Early Manifestation of Diabetic Cardiomyopathy
Schannwell, C. M., Schneppenheim, M., Perings, S. M., Plehn, G., & Strauer, B. E. (2002) · Cardiology · doi:10.1159/000064682 · Cited by 330 · see citing works
Sun, F., Wu, S., Guo, S., Yu, K., Yang, Z., Li, L., Zhang, Y., Quan, X., Ji, L., & Zhan, S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.07.015 · Cited by 304 · see citing works
Sonne, D. P., Engstrøm, T., & Treiman, M. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.10.001 · Cited by 294 · see citing works
Nauck, M. A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.002 · Cited by 293 · see citing works
Sohn, D., Song, J., Zo, J., Chai, I.-H., Kim, H.-S., Chun, H., & Kim, H. C. (1999) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(99)70145-8 · Cited by 278 · see citing works
Sokos, G. G., Bölükoglu, H., German, J., Hentosz, T. M., Magovern, G. J., Maher, T. D., Dean, D. A., Bailey, S. H., MARRONE, G. C., Benckart, D. H., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.05.022 · Cited by 253 · see citing works
Seino, Y., & Yabe, D. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12065 · Cited by 247 · see citing works
Blonde, L., & Russell-Jones, D. L. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01075.x · Cited by 227 · see citing works
Wang, M., Yip, G. W., Yu, C., Zhang, Q., Zhang, Y., Tse, D., Kong, S., & Sanderson, J. E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.059 · Cited by 220 · see citing works
Clinical evaluation of left ventricular diastolic performance
Little, W. C., & Downes, T. R. (1990) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(90)90017-v · Cited by 218 · see citing works
Courrèges, J. P., Vilsbøll, T., Zdravkovic, M., Le-Thi, T., Krarup, T., Schmitz, O., Verhoeven, R., Bugáňová, I., & Madsbad, S. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02484.x · Cited by 191 · see citing works
Poornima, I. G., Brown, S. B., Bhashyam, S., Parikh, P., Bölükoglu, H., & Shannon, R. P. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.766402 · Cited by 182 · see citing works
The Prevalence of Diabetic Cardiomyopathy: A Population-Based Study in Olmsted County, Minnesota
Dandamudi, S., Slusser, J. P., Mahoney, D. W., Redfield, M. M., Rodeheffer, R. J., & Chen, H. H. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.02.007 · Cited by 160 · see citing works
Changes in Diastolic Dysfunction in Diabetes Mellitus Over Time
From, A. M., Scott, C. G., & Chen, H. H. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.358 · Cited by 152 · see citing works
Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?
Cosson, S., & Kévorkian, J.-P. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70059-9 · Cited by 129 · see citing works
Fonseca, V. A., DeVries, J. H., Henry, R. R., Donsmark, M., Thomsen, H. F., & Plutzky, J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.01.009 · Cited by 98 · see citing works
Nathanson, D., Ullman, B., Löfström, U., HEDMAN, A. G., Frick, M., Sjöholm, Å., & Nyström, T. (2012) · Diabetologia · doi:10.1007/s00125-011-2440-x · Cited by 96 · see citing works
Dinh, W., Lankisch, M., Nickl, W., Scheyer, D., Scheffold, T., Kramer, F., Krahn, T., Klein, R. M., Barroso, M. C., & Füth, R. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-63 · Cited by 87 · see citing works
Assessment of Subendocardial Structure and Function
Stanton, T., & Marwick, T. H. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.05.011 · Cited by 77 · see citing works
GLP ‐1 Receptor Agonists: Effects on Cardiovascular Risk Reduction
Lorber, D. (2013) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12000 · Cited by 77 · see citing works
Diastolic dysfunction: Improved understanding using emerging imaging techniques
Daneshvar, D. A., Wei, J., Tolstrup, K., Thomson, L., SHUFELT, C. L., & Merz, C. N. B. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.06.040 · Cited by 71 · see citing works
Liu, J., Liu, Y., Chen, L., Wang, Y., & Li, J. (2013) · Journal of Diabetes Research · doi:10.1155/2013/630537 · Cited by 48 · see citing works
Park, H. S., Naik, S. D., Aronow, W. S., Visintainer, P., Das, M., McClung, J. A., & Belkin, R. N. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.04.044 · Cited by 40 · see citing works
Ji, Y., Zhao, Z., Cai, T., Yang, P., & Cheng, M. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1956 · Cited by 37 · see citing works
Pugliese, G., Solini, A., Bonora, E., Orsi, E., Zerbini, G., Fondelli, C., Gruden, G., Cavalot, F. L., Lamacchia, O., Trevisan, R., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-59 · Cited by 34 · see citing works
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Mannucci E, Bergenstal R, Daniels G, Mann J, Nissen S, Zinman B, et al. Liraglutide effects and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial: rationale and study design. Diabetes 2011;60:A612-3.
- Fonseca V, Falahati A, Zychma M, Madsbad S, Plutzky J. A meta-analysis of six clinical trials demonstrates that the once-daily human GLP-1 analogue liraglutide reduces systolic blood pressure. J Diab Compl 2014;28(3):399-405.
Cited by
Sorted by citations
Roslan, J., Giribabu, N., Karim, K., & Salleh, N. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.044 · Cited by 149 · see citing works
Bizino, M. B., Jazet, I. M., Westenberg, J. J. M., van Eyk, H. J., Paiman, E. H. M., Smit, J. W. A., & Lamb, H. J. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0857-6 · Cited by 137 · see citing works
Yamada, H., Tanaka, A., Kusunose, K., Amano, R., Matsuhisa, M., Daida, H., Ito, M., Tsutsui, H., Nanasato, M., Kamiya, H., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0546-2 · Cited by 77 · see citing works
The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF
Withaar, C., Meems, L. M. G., Nollet, E. E., Schouten, E. M., Schroeder, M. A., Knudsen, L. B., Niss, K., Madsen, C. T., Hoegl, A., Mazzoni, G., et al. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.012 · Cited by 74 · see citing works
Ussher, J. R., Greenwell, A. A., Nguyen, M.-A., & Mulvihill, E. E. (2022) · Diabetes · doi:10.2337/dbi20-0049 · Cited by 51 · see citing works
Karakasis, P., Vlachos, K. G., Antoniadis, A. P., Siontis, K. C., Patoulias, D., Fragakis, N., & Mantzoros, C. S. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156463 · Cited by 48 · see citing works
Jørgensen, P. G., Jensen, M. T., Mensberg, P., Storgaard, H., Nyby, S., Jensen, J. S., Knop, F. K., & Vilsbøll, T. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12900 · Cited by 36 · see citing works
Packer, M. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.08.027 · Cited by 33 · see citing works
The Impact of Antidiabetic Therapies on Diastolic Dysfunction and Diabetic Cardiomyopathy
Gopal, K., Chahade, J. J., Kim, R., & Ussher, J. R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.603247 · Cited by 32 · see citing works
Kumarathurai, P., Sajadieh, A., Anholm, C., Kristiansen, O. P., Haugaard, S. B., & Nielsen, O. W. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01205-2 · Cited by 31 · see citing works
Liraglutide relieves cardiac dilated function than DPP ‐4 inhibitors
Hiramatsu, T., Asano, Y., Mabuchi, M., Imai, K., Iguchi, D., & Furuta, S. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13007 · Cited by 27 · see citing works
Ghoreyshi‐Hefzabad, S., Jeyaprakash, P., Gupta, A., Vo, H. Q., Pathan, F. K., & Negishi, K. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020811 · Cited by 26 · see citing works
Nyström, T., Santos‐Pardo, I., Hedberg, F., Wardell, J., Witt, N., Cao, Y., Bojö, L., Nilsson, B., & JENDLE, J. H. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00325 · Cited by 26 · see citing works
Warbrick, I., & Rabkin, S. W. (2018) · Peptides · doi:10.1016/j.peptides.2018.05.009 · Cited by 26 · see citing works
Strategies of Unloading the Failing Heart from Metabolic Stress
Koutroumpakis, E., Jozwik, B., Aguilar, D. A., & Taegtmeyer, H. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.08.035 · Cited by 24 · see citing works
Durak, A. T., Akkuş, E., Canpolat, A. G., Tuncay, E., Çorapçıoğlu, D., & Turan, B. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13590 · Cited by 23 · see citing works
New antidiabetic therapy and HFpEF: light at the end of tunnel?
Tadic, M. V., Sala, C., Saeed, S., Grassi, G. M., Mancia, G., Rottbauer, W., & Cuspidi, C. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10106-9 · Cited by 23 · see citing works
Cardiac fibrosis: emerging agents in preclinical and clinical development
Spoladore, R., Falasconi, G., Fiore, G., Maio, S. D., Preda, A., Slavich, M., Margonato, A., & Fragasso, G. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1868432 · Cited by 19 · see citing works
Yagi, K., Imamura, T., Tada, H., Chujo, D., Liu, J., Shima, Y., Ohbatake, A., Miyamoto, Y., Okazaki, S., Ito, N., et al. (2021) · Journal of Diabetes Research · doi:10.1155/2021/8838026 · Cited by 18 · see citing works
Velagic, A., Li, M., Deo, M., Li, J. C., Kiriazis, H., Donner, D. G., Anderson, D., Blasio, M. J. D., Woodman, O. L., Kemp‐Harper, B. K., et al. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00390.2022 · Cited by 17 · see citing works
The potential of glucagon-like peptide-1 receptor agonists in heart failure
Kreiner, F. F., Hovingh, G. K., & von Scholten, B. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.983961 · Cited by 16 · see citing works
Recent update on biological activities and pharmacological actions of liraglutide
Tiwari, J., Gupta, G., Dahiya, R., Pabreja, K., Sharma, R. K., Mishra, A., & Dua, K. (2017) · EXCLI journal · doi:10.17179/excli2017-323 · Cited by 16 · see citing works
A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis
Burelle, C., Clapatiuc, V., Deschênes, S., Cuillerier, A., Loof, M. D., Higgins, M., Boël, H., Daneault, C., Chouinard, B., Clavet‐Lanthier, M., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06035-6 · Cited by 15 · see citing works
Bojer, A. S., Sørensen, M. H., Bjerre, J., Gæde, P., Vejlstrup, N. G., & Madsen, P. L. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14480 · Cited by 14 · see citing works
Key factors of diastolic dysfunction and abnormal left ventricular relaxation in diabetic rats
Kitpipatkun, P., Matsuura, K., Shimada, K., Uemura, A., Goya, S., Yoshida, T., Ma, D., Takahashi, K., & Tanaka, R. (2020) · Journal of Medical Ultrasonics · doi:10.1007/s10396-020-01021-x · Cited by 14 · see citing works
Diastolic dysfunction in hypertension
Leão, R. N., & da Silva, P. M. (2017) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2017.01.001 · Cited by 13 · see citing works
Mather, K. J., Considine, R. V., Hamilton, L., Patel, N. A., Mathias, C. J., Territo, W. L., Goodwill, A. G., Tune, J. D., Green, M. A., & Hutchins, G. D. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00712 · Cited by 6 · see citing works
[Exendin-4 alleviates diabetic cardiomyopathy in mice by regulating Sirt1/PGC1α].
Cai, Y., Zou, S., Fan, C., Wu, C., Fang, S., Li, P., Xue, Y., & Guan, M. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.05.03 · Cited by 6 · see citing works
Thomas, J., Dagan, M., Wang, B. H., Gutman, S., & Kaye, D. M. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013279 · Cited by 7 · see citing works
Muñoz, P. A., Celermajer, D. S., Gu, Y., Bradley, S., Wong, J., Constantino, M., McLennan, S., Lau, E., Alison, J. A., & Harmer, A. R. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.11.003 · Cited by 5 · see citing works
Effect of Liraglutide on Cardiac Function in Individuals With Type 2 Diabetes: A Meta-Analysis
Haroon, H., Kumari, A., Lal, B., Kumari, A., Kumar, J., Khreis, K., Sheikh, M., & Amin, A. (2023) · Cureus · doi:10.7759/cureus.42651 · Cited by 4 · see citing works
Goodman, J. A., Schain, M., Stefano, G. D., Lupson, V. C., Horn, T., Hill, M., Manavaki, R., Fryer, T. D., Bumanlag-Amis, E., Jalaludeen, N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-04559-3 · Cited by 5 · see citing works
Epicardial Adipose Tissue: A Potential Target to Improve Left Ventricular Diastolic Dysfunction
Ran, C.-Q., & He, W. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm39224 · Cited by 3 · see citing works
Avaliação do consumo de medicamentos emagrecedores dispensado em uma drogaria
Martins, J. S., Moura, M. B. D. S., & Britto, M. H. R. M. (2020) · Research Society and Development · doi:10.33448/rsd-v9i6.3315 · Cited by 3 · see citing works
Grigorescu, E.-D., Lăcătușu, C.-M., Floria, M., Cazac, G.-D., Onofriescu, A., Sauciuc, L. A., Ceasovschih, A., Crețu, I., Mihai, B. M., & Șorodoc, L. (2023) · Diagnostics · doi:10.3390/diagnostics13172817 · Cited by 2 · see citing works
Fan, Y., Chen, X., Cai, X., Dong, Y., Liu, C., Chen, Y., Lip, G. Y. H., & Zhu, W. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156678 · Cited by 1 · see citing works
王, 传. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361253 · Cited by 1 · see citing works
Ризвановна, А. М., & Zhernakova, J. (2021) · Systemic Hypertension · doi:10.26442/2075082x.2021.4.201305
Thakkar, H. V., & Negishi, K. (2021) · Diastology · doi:10.1016/b978-0-323-64067-1.00028-0
Ризвановна, А. М., Zhernakova, Y. V., Saidova, M. A., & Chazova, I. E. (2022) · Systemic Hypertension · doi:10.38109/2075-082x-2022-1-39-48
Echocardiographic evaluation and clinical implications of cardiac remodeling in obesity
Okushi, Y., Takahashi, T., & Kusunose, K. (2026) · Journal of Echocardiography · doi:10.1007/s12574-026-00721-6
- Authors
- Saponaro, F., Sonaglioni, A., Rossi, A., Montefusco, L., Lombardo, M., Adda, G., & Arosio, M.
- Affiliations
- MultiMedica (IT)
- University of Milan (IT)
- Corresponding author
- Arosio, Maura
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 118
- Pages
- 21-28
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2346769585
- Cited by
- 41
- References
- 47
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 1
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Research and Clinical Practice (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- liraglutide, type 2 diabetes, diastolic function, GLP-1 receptor agonists, mitral annular velocity, tissue Doppler imaging, myocardial relaxation, HbA1c, glycemic control
- MeSH terms
- Liraglutide, Adolescent, Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Diastole, Drug Administration Schedule, Female, Follow-Up Studies, Heart Ventricles, Humans, Hypoglycemic Agents, Male, Middle Aged, Prospective Studies, Echocardiography, Doppler, Ventricular Function, Left, Young Adult, Diabetic Cardiomyopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
